Pulse.

a daily field guide to health research that matters

◆ Console

‹ Sun · 1 Nov 2026
Standard addition

Transcriptomic Features Associated With Kinase Inhibitor Sensitivity in KMT2A-Rearranged AML.

Certain genetic patterns in aggressive blood cancer correlate with sensitivity to kinase inhibitors, helping narrow treatment options in the laboratory.

This retrospective transcriptomic drug-sensitivity analysis examined Transcriptomic Features Associated With Kinase Inhibitor Sensitivity in KMT2A-Rearranged AML. A KMT2A -r-like transcriptomic state is associated with candidate kinase inhibitor sensitivity patterns in primary AML datasets and appears linked to, but not fully explained by, FLT3 -related biology.

What the study was

Study design
Retrospective transcriptomic drug-sensitivity analysis
Category
Genomics/Precision Medicine
Maturity
Exploratory
Journal
Cancer genomics & proteomics

Why it surfaced

Abstract-backed retrospective transcriptomic drug-sensitivity analysis relevant to Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma); scored conservatively because full text was not assessed.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.